Omalizumab and food allergy: does reaction severity
improve in adult patients?

Özge Argın; Zeynep Yegin Katran; İsmet Bulut

doi:10.5114/ada.2026.161822

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors Publication charge

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Send email

Copy url:

Original paper

Omalizumab and food allergy: does reaction severity improve in adult patients?

Özge Argın

¹

,

Zeynep Yegin Katran

¹

,

İsmet Bulut

¹

Department of Allergy and Immunology, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye

Adv Dermatol Allergol

DOI: https://doi.org/10.5114/ada.2026.161822

Online publish date: 2026/05/16

Article file

- Omalizumab and food - Argin.pdf [0.16 MB]

Get citation

1. Wood RA, Togias A, Sicherer SH, et al. Omalizumab for the treatment of multiple food allergies. N Engl J Med 2024; 390: 889-99.

2. Santos AF, Riggioni C, Agache I, et al. EAACI guidelines on the management of IgE-mediated food allergy. Allergy 2025; 80: 14-36.

3. Riggioni C, Oton T, Carmona L, et al. Immunotherapy and biologics in the management of IgE-mediated food allergy: systematic review and meta-analyses of efficacy and safety. Allergy 2024; 79: 2097-127.

4. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466-9.

5. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114: 371-6.

6. Anvari S, Miller J, Yeh CY, et al. IgE-mediated food allergy. Clin Rev Allergy Immunol 2019; 57: 244-60.

7. Arasi S, Mennini M, Cafarotti A, et al. Omalizumab as monotherapy for food allergy. Curr Opin Allergy Clin Immunol 2021; 21: 286-91.

8. Mustafa SS, Sokol K. Omalizumab in food allergy: risks and benefits. J Food Allergy 2024; 7: 7-13.

9. Bird JA, Near AM, Wang J, et al. Health care resource utilization of patients with asthma and food allergy initiating omalizumab. J Allergy Clin Immunol Glob 2025; 4: 100491.

10. Casale TB, Fiocchi A, Greenhawt M. A practical guide for implementing omalizumab therapy for food allergy. J Allergy Clin Immunol 2024; 153: 1510-7.

11. Anagnostou A, Bird JA, Chinthrajah S, et al. The use and implementation of omalizumab as food allergy treatment: consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2025; 155: 62-9. e1.

12. Wertenteil S, Strunk A, Garg A. Prevalence estimates for chronic urticaria in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol 2019; 81: 152-6.

13. Aurich S, Dölle-Bierke S, Francuzik W, et al. Anaphylaxis in elderly patients-data from the European Anaphylaxis Registry. Front Immunol 2019; 10: 750.

14. Arasi S, Morais-Almeida M, Martin BL, et al. Food allergy severity across the world: a World Allergy Organization international survey. World Allergy Organ J 2025; 18: 101123.

15. Sompornrattanaphan M, Ajalasaereewong S, Wongsa C, et al. Prevalence and characteristics of adult patients with adult-onset and childhood-onset food allergy. Asian Pac J Allergy Immunol 2023 https://doi.org/10.12932/ap-210223-1548.

16. Anagnostou A, Greenhawt M, Shaker M, et al. Food allergy yardstick: where does omalizumab fit? Ann Allergy Asthma Immunol 2025; 134: 110-21.

17. Sampson HA, Bird JA, Fleischer D, et al. Who are the potential patients for omalizumab for food allergy? Ann Allergy Asthma Immunol 2024; 132: 569-71.

18. Zhang Y, Liang B, Tian L, et al. Systematic review and meta-analysis of omalizumab for IgE-mediated food allergy in children and young adults. Front Immunol 2025; 16: 1690650.

19. Kolkhir P, André F, Church MK, et al. Potential blood biomarkers in chronic spontaneous urticaria. Clin Exp Allergy 2017; 47: 19-36.

20. Brough HA, Kim EH, Anagnostou A, et al. Treatment of food allergy: immunotherapy, omalizumab, or both. J Allergy Clin Immunol Pract 2025; 13: 731-9.

21. Zuberbier T, Wood RA, Bindslev-Jensen C, et al. Omalizumab in IgE-mediated food allergy: a systematic review and meta-analysis. J Allergy Clin Immunol Pract 2023; 11: 1134-46.

22. Kulis MD, Humphrey JR, Krempski JW, et al. Anti-IgE therapy versus allergen-specific immunotherapy for food allergy: weighing the pros and cons. Front Immunol 2025; 16: 1617153.

Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Omalizumab and food allergy: does reaction severity improve in adult patients?

Özge Argın 1 , Zeynep Yegin Katran 1 , İsmet Bulut 1

Özge Argın

¹

,

Zeynep Yegin Katran

¹

,

İsmet Bulut

¹